134 related articles for article (PubMed ID: 18227181)
1. In vitro interactions of micafungin with amphotericin B against clinical isolates of Candida spp.
Serena C; Mariné M; Quindós G; Carrillo AJ; Cano JF; Pastor FJ; Guarro J
Antimicrob Agents Chemother; 2008 Apr; 52(4):1529-32. PubMed ID: 18227181
[TBL] [Abstract][Full Text] [Related]
2. Killing kinetics of caspofungin, micafungin, and amphotericin B against Candida guilliermondii.
Cantón E; Pemán J; Sastre M; Romero M; Espinel-Ingroff A
Antimicrob Agents Chemother; 2006 Aug; 50(8):2829-32. PubMed ID: 16870779
[TBL] [Abstract][Full Text] [Related]
3. In vitro combination therapy with isavuconazole against Candida spp.
Katragkou A; McCarthy M; Meletiadis J; Hussain K; Moradi PW; Strauss GE; Myint KL; Zaw MH; Kovanda LL; Petraitiene R; Roilides E; Walsh TJ; Petraitis V
Med Mycol; 2017 Nov; 55(8):859-868. PubMed ID: 28204571
[TBL] [Abstract][Full Text] [Related]
4. In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp.
Yustes C; Guarro J
Antimicrob Agents Chemother; 2005 Aug; 49(8):3498-500. PubMed ID: 16048969
[TBL] [Abstract][Full Text] [Related]
5. Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.
Marcos-Zambrano LJ; Gómez-Perosanz M; Escribano P; Zaragoza O; Bouza E; Guinea J
Antimicrob Agents Chemother; 2016 Jun; 60(6):3579-86. PubMed ID: 27021323
[TBL] [Abstract][Full Text] [Related]
6. In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
Nishi I; Sunada A; Toyokawa M; Asari S; Iwatani Y
J Infect Chemother; 2009 Feb; 15(1):1-5. PubMed ID: 19280292
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of micafungin combined with itraconazole against Candida spp.
Mariné M; Serena C; Pastor J; Quindós G; Carrillo AJ; Guarro J
Int J Antimicrob Agents; 2007 Nov; 30(5):463-5. PubMed ID: 17698327
[TBL] [Abstract][Full Text] [Related]
8. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
[TBL] [Abstract][Full Text] [Related]
9. Effect of the growth medium on the in vitro antifungal activity of micafungin (FK-463) against clinical isolates of Candida dubliniensis.
Müller FM; Kurzai O; Hacker J; Frosch M; Mühlschlegel F
J Antimicrob Chemother; 2001 Nov; 48(5):713-5. PubMed ID: 11679561
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.
Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2008 Jan; 46(1):150-6. PubMed ID: 18032613
[TBL] [Abstract][Full Text] [Related]
11. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the antifungal activity of micafungin and amphotericin B against Candida tropicalis biofilms.
Marcos-Zambrano LJ; Escribano P; Bouza E; Guinea J
J Antimicrob Chemother; 2016 Sep; 71(9):2498-501. PubMed ID: 27147303
[TBL] [Abstract][Full Text] [Related]
13. Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and Candida.
Warn PA; Sharp A; Guinea J; Denning DW
J Antimicrob Chemother; 2004 May; 53(5):743-9. PubMed ID: 15044422
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006.
Dannaoui E; Lortholary O; Raoux D; Bougnoux ME; Galeazzi G; Lawrence C; Moissenet D; Poilane I; Hoinard D; Dromer F;
Antimicrob Agents Chemother; 2008 Feb; 52(2):778-81. PubMed ID: 18070978
[TBL] [Abstract][Full Text] [Related]
15. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y
Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis.
Fleischhacker M; Radecke C; Schulz B; Ruhnke M
Eur J Clin Microbiol Infect Dis; 2008 Feb; 27(2):127-31. PubMed ID: 18057972
[TBL] [Abstract][Full Text] [Related]
17. In vitro interaction of micafungin and fluconazole against Candida.
Rodríguez MM; Ruiz M; Pastor FJ; Quindós G; Carrillo A; Guarro J
J Antimicrob Chemother; 2007 Jul; 60(1):188-90. PubMed ID: 17525050
[No Abstract] [Full Text] [Related]
18. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
Heyn K; Tredup A; Salvenmoser S; Müller FM
Antimicrob Agents Chemother; 2005 Dec; 49(12):5157-9. PubMed ID: 16304192
[TBL] [Abstract][Full Text] [Related]
19. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
[TBL] [Abstract][Full Text] [Related]
20. Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms.
Kovács R; Bozó A; Gesztelyi R; Domán M; Kardos G; Nagy F; Tóth Z; Majoros L
Int J Antimicrob Agents; 2016 Apr; 47(4):304-10. PubMed ID: 26968084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
